Immune response and possible therapeutics in COVID-19

COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Anindya, Roy, Ananya, Roy, Laboni, Chattopadhyay, Samit, Chatterjee, Subhrangsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693424/
https://www.ncbi.nlm.nih.gov/pubmed/35423713
http://dx.doi.org/10.1039/d0ra08901j
_version_ 1784619139771400192
author Dutta, Anindya
Roy, Ananya
Roy, Laboni
Chattopadhyay, Samit
Chatterjee, Subhrangsu
author_facet Dutta, Anindya
Roy, Ananya
Roy, Laboni
Chattopadhyay, Samit
Chatterjee, Subhrangsu
author_sort Dutta, Anindya
collection PubMed
description COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19.
format Online
Article
Text
id pubmed-8693424
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-86934242022-04-13 Immune response and possible therapeutics in COVID-19 Dutta, Anindya Roy, Ananya Roy, Laboni Chattopadhyay, Samit Chatterjee, Subhrangsu RSC Adv Chemistry COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19. The Royal Society of Chemistry 2021-01-04 /pmc/articles/PMC8693424/ /pubmed/35423713 http://dx.doi.org/10.1039/d0ra08901j Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Dutta, Anindya
Roy, Ananya
Roy, Laboni
Chattopadhyay, Samit
Chatterjee, Subhrangsu
Immune response and possible therapeutics in COVID-19
title Immune response and possible therapeutics in COVID-19
title_full Immune response and possible therapeutics in COVID-19
title_fullStr Immune response and possible therapeutics in COVID-19
title_full_unstemmed Immune response and possible therapeutics in COVID-19
title_short Immune response and possible therapeutics in COVID-19
title_sort immune response and possible therapeutics in covid-19
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693424/
https://www.ncbi.nlm.nih.gov/pubmed/35423713
http://dx.doi.org/10.1039/d0ra08901j
work_keys_str_mv AT duttaanindya immuneresponseandpossibletherapeuticsincovid19
AT royananya immuneresponseandpossibletherapeuticsincovid19
AT roylaboni immuneresponseandpossibletherapeuticsincovid19
AT chattopadhyaysamit immuneresponseandpossibletherapeuticsincovid19
AT chatterjeesubhrangsu immuneresponseandpossibletherapeuticsincovid19

Ejemplares similares